mRNA-4157,Pembrolizumab
Moderna,Merck
['mrna-4157', 'melanoma', 'pembro']
adjuvant mrna-4157 vaccine + pembro prolongs dmfs (hr 0.35 ) compared to pembro alone in patients with resected high-risk stage iiib/c/d and iv melanoma. this adds up to the previously reported improvement in rfs. waiting for the phase iii trial!!! #asco2023 
29. MD. PhD student. Medical Oncologist. ES 🇪🇸| EN 🇬🇧| FR 🇫🇷| ZH 🇨🇳| 救死扶傷 ⚕️Avid traveller! ✈️🌏